EBIX Regulatory Approval

Other Announcement

EBIX Other Announcement

Ebix's monitoring agency flags Rs.46.15 crore of warrant proceeds moved to subsidiaries for working capital in Q1FY27. It notes a 10-25% deviation, with subsidiary statements still unreceived.

Other Announcement

EBIX Other Announcement

Ebix Ltd has filed its quarterly shareholding pattern as per Regulation 31(1)(b) of the SEBI (LODR) Regulations for the period ending September 30, 2026.

Management Change

EBIX Management Change

EBIX Ltd appointed three new Independent Directors and noted cessation of three existing ones, effective October 6, 2026. The board reconstitution follows NCLT directions and NRC recommendations.

Annual General Meeting

EBIX Annual General Meeting

Ebix Limited conducted its 60th Annual General Meeting on September 30, 2026. The proceedings covered the adoption of financial statements and a business performance overview.

Annual Report

EBIX Annual Report

Ebix Limited has filed its 60th Annual Report for the financial year 2025-26 with the stock exchange, fulfilling its regulatory compliance obligations.

Annual General Meeting

EBIX Annual General Meeting

Ebix Limited has scheduled the closure of its register of members and share transfer books from September 24, 2026, to September 30, 2026, for its AGM.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.

Regulatory ApprovalJohn Cockerill India Ltd COCKERILLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.

Regulatory ApprovalGland Pharma Ltd GLANDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.

Regulatory ApprovalCity Union Bank Ltd CUBAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

City Union Bank Regulatory Approval

City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.

Execution

Three years from the date of taking charge

Regulatory ApprovalLupin Ltd LUPINAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Lupin Regulatory Approval

Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.

Regulatory ApprovalSom Distilleries & Breweries Ltd SDBLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Som Distilleries & Breweries Regulatory Approval

Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.